Starnes VA, Lewiston N, Theodore J, Stoehr C, Sinson E, Shumway NE, Oyer PE. 
Cystic fibrosis. J Thorac Cardiovasc Surg 1992; 103: 1008-1014 
Stern RC , Boat TF, Doershuk CF. Obstructive azoospermia as a diagnostic 
criterion for the cystic fibrosis syndrome. Lancet 1982; 1: 1401-1403 
Stewart PL, Burnett RM, Cyrklaff M, Fuller SD. Image reconstruction reveals 
the complex molecular organization of adenovirus. Cell 1991; 67: 145 
Stoller JK. Further specification and evaluation of a new clinical index for 
dyspnea. Am Rev Respir Dis 1986; 134: 1129-1134 
Straus, S.E. (1984) in The Adenoviruses (Ginsberg HS , ed.), pp . 451-496, 
Plenum Press, New York, London 
Suter S, Schaad UB, Morgenthaler JJ , Chevallier I, Schnebli HP. 
Fibronectin-cleaving activity in bronchial secretions of patients with cystic 
fibrosis. J Infect Dis 1988; 158 (1): 89-100 
Suter S . The imbalance between granulocyte neutral proteases and antiproteases 
in bronchial secretions from patients with cystic fibrosis. Antibiot Chemother 
1989a; 42: 158-168 
Suter S, Schaad UB, Roux-Lombard P, Giradin E, Grau G, Dayer J-M. Relation 
between tumor necrosis factor-alpha and granulocyte elastase-al-proteinase 
inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev 
Respir Dis 1989b; 140: 1640-1644 
Tacket CO, Lonsonsky G, Lubeck MD, Davis AR, Mizutani S, Horwith G, Hung P, 
Edelman R, Levine MM. Initial safety and immunogenicity studies of an oral 
recombinant adenohepatitis B vaccine. Vaccine 1992; 10: 673-676. 
The Commission on Acute Respiratory Diseases. Experimental transmission of 
minor respiratory illness to human volunteers by filter-passing agents. I. 
Demonstration of two types of illness characterized by long and short 
incubation periods and different clinical features. J Clin Invest 1947a; 26: 
957-973 
The Commission on Acute Respiratory Diseases. Experimental transmission of 
minor respiratory illness to human volunteers by filter-passing agents. II. 
Immunity on reinoculation with agents from the two types of minor respiratory 
illness and from primary atypical pneumonia. J Clin Invest 1947b; 26: 974-982 
Tollefson AE, Krajcsi P, Pursley MH, Gooding LR, Wold WS . A 14,500 MW protein 
is coded by region E3 of group C humann adenoviruses. Virology 1990a; 175: 19 
Tollefson AE, Krajcsi P, Yei SP, Carlin CR, Wold WS . A 10,400-molecular-weight 
membrane protein is coded by region E3 of adenovirus. J Virol 1990b; 64: 794- 
801 
Tollefson AE, Stewart AR, Yei S, Saha SK, Wold WSM. The 10,400- and 
[802] 
Recombinant DNA Research, Volume 16 
